MedTrace Logo

Hydroxychloroquine Efficacy in Chronic Urticaria

NCT01073852 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2013-01-23

No results posted yet for this study

Summary

This study is for those people with difficult to treat hives. We are investigating whether or not a different medication, hydroxychloroquine, works to treat a certain type of hives. Hydrochloroquine is currently approved by the Food and Drug Administration (FDA), for treating arthritis, therefore it is considered investigational in this study.

Hypothesis: Hydroxychloroquine will prove to have an efficacious response in terms of Urticarial Symptoms, on patients with chronic urticaria.

Conditions

  • Chronic Urticaria

Interventions

DRUG

Placebo

Placebo pill, 1 pill orally twice daily for 9 weeks.

DRUG

Hydroxychloroquine

Patients will be taking hydroxychloroquine 200mg orally twice/daily.

Sponsors & Collaborators

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Pogie Pongonis, MD · Vanderbilt University

  • John Fahrenholz, MD · Vanderbilt University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2012-06-30
Completion
2012-06-30

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01073852 on ClinicalTrials.gov